Celldex Therapeutics

celldex.com

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

MARINUS PHARMACEUTICALS ANNOUNCES NEW METHOD OF USE PATENT GRANTED FOR IV GANAXOLONE BY USPTO IN STATUS EPILEPTICUS

Businesswire | June 26, 2023

news image

Marinus Pharmaceuticals, Inc. a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the United States Patent and Trademark Office (USPTO) has granted a new method of use patent for intravenous (IV) ganaxolone in the treatment of status epilepticus (SE), expiring in 2040. The USPTO issued U.S. Patent No. 11,679,117, covering the clinical dosing regimen administering ganaxolone for SE patients, including t...

Read More

Business Insights, PHARMACY MARKET

MASSIVE BIO AND NEOGENOMICS ANNOUNCE COLLABORATION TO ACCELERATE ONCOLOGY DRUG DISCOVERY AND IMPROVE PATIENT CARE

Businesswire | March 27, 2023

news image

Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating the development of new cancer therapies and ultimately improving the lives of millions of cancer patients around the world. NeoGenomics will identify patients in real ...

Read More

Pharma Tech

VOW INC. JOINS PORTFOLIO OF K1, A LEADING INVESTMENT FIRM FOCUSING ON HIGH-GROWTH SOFTWARE COMPANIES GLOBALLY

Digital Pharmacist | October 11, 2021

news image

Vow, a leading provider of interactive phone systems to the pharmacy industry, announced its strategic partnership with Digital Pharmacist, a software company that powers digital communication and adherence solutions for over 7,000 pharmacies. Together, the combined businesses establish an industry leading portfolio of solutions that automate pharmacy operations and enhance patient communications through its core solutions: Patient Engagement Platform, interactive voice response (IVR), website, ...

Read More

Business Insights

CATALENT ANNOUNCES NEW OPERATING STRUCTURE

Catalent, Inc | July 06, 2022

news image

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced changes to its operating structure and executive leadership team that went into effect July 1. This new organizational structure includes a shift from four reporting segments to two, each representing roughly half of the total company revenue. According to Alessandro Mas...

Read More
news image

Pharmacy Market

MARINUS PHARMACEUTICALS ANNOUNCES NEW METHOD OF USE PATENT GRANTED FOR IV GANAXOLONE BY USPTO IN STATUS EPILEPTICUS

Businesswire | June 26, 2023

Marinus Pharmaceuticals, Inc. a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the United States Patent and Trademark Office (USPTO) has granted a new method of use patent for intravenous (IV) ganaxolone in the treatment of status epilepticus (SE), expiring in 2040. The USPTO issued U.S. Patent No. 11,679,117, covering the clinical dosing regimen administering ganaxolone for SE patients, including t...

Read More
news image

Business Insights, PHARMACY MARKET

MASSIVE BIO AND NEOGENOMICS ANNOUNCE COLLABORATION TO ACCELERATE ONCOLOGY DRUG DISCOVERY AND IMPROVE PATIENT CARE

Businesswire | March 27, 2023

Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating the development of new cancer therapies and ultimately improving the lives of millions of cancer patients around the world. NeoGenomics will identify patients in real ...

Read More
news image

Pharma Tech

VOW INC. JOINS PORTFOLIO OF K1, A LEADING INVESTMENT FIRM FOCUSING ON HIGH-GROWTH SOFTWARE COMPANIES GLOBALLY

Digital Pharmacist | October 11, 2021

Vow, a leading provider of interactive phone systems to the pharmacy industry, announced its strategic partnership with Digital Pharmacist, a software company that powers digital communication and adherence solutions for over 7,000 pharmacies. Together, the combined businesses establish an industry leading portfolio of solutions that automate pharmacy operations and enhance patient communications through its core solutions: Patient Engagement Platform, interactive voice response (IVR), website, ...

Read More
news image

Business Insights

CATALENT ANNOUNCES NEW OPERATING STRUCTURE

Catalent, Inc | July 06, 2022

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced changes to its operating structure and executive leadership team that went into effect July 1. This new organizational structure includes a shift from four reporting segments to two, each representing roughly half of the total company revenue. According to Alessandro Mas...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us